AsianScientist (Aug. 28, 2025) – Agilent Applied sciences isn’t any stranger to transformation. For greater than 20 years, the scientific-instruments chief has grown its footprint in Singapore from regional base to globally acknowledged innovation hub—certainly one of solely 5 native services named by the World Financial Discussion board as a Lighthouse for superior manufacturing.
Now, with a newly launched enterprise-wide transformation known as Ignite, Agilent is sharpening its buyer focus and doubling down on collaboration, digitalization and agility. Padraig McDonnell, president and CEO of Agilent, discusses the corporate’s evolving priorities, Singapore’s strategic position and the multiplier impact of partnership.
1. Agilent has had a powerful presence in Singapore for over 25 years. Why was it essential to develop into Southeast Asia, and the way has this proved useful for each Agilent and Singapore?
Singapore has performed an enormous position in Agilent’s progress story. On the highest degree, we’re right here to carry nice science to life, and that involves life by means of our deep concentrate on clients and enabling outcomes in life sciences, diagnostics and utilized markets. Southeast Asia, and Asia extra broadly, is a fast-growing and numerous area.
Singapore has been an incredible hub in Asia for us. We now have over 600 expert scientists, engineers and different staff right here and a 172,000 sq. foot facility. Over time, we’ve expanded from automation to mass spectrometry options. In 2017, our funding of S$85 million in manufacturing and analysis actions embodies the belief we have now in Singapore’s innovation ecosystem.
What makes Singapore particularly engaging is the mixture of geographic benefit, world-class infrastructure, pro-innovation insurance policies and robust IP safety. Above all, it’s the expertise and functionality—we worth Singapore’s concentrate on growing expertise in each scientific areas and management.
2. Agilent just lately launched its Ignite transformation. What’s the strategic imaginative and prescient behind it and the way will clients profit?
It’s a company-wide transformation designed to assist us scale extra successfully and serve clients higher. The technique is centered on markets and clients, not simply merchandise, and that shift helps us keep aligned with what issues most to the folks we serve.
We now have a long-range plan of 5 to 7% core income progress yearly and double-digit earnings per share (EPS) progress. Ignite can be about how we function. We need to simplify world processes, scale back complexity and construct a extra agile worth chain.
For patrons, this implies shorter lead occasions, better consistency and high quality, and quicker response to their wants. It additionally means quicker product launches and co-innovation. As an illustration, in areas like PFAS evaluation or biopharma workflows, we’re accelerating how rapidly analytical devices attain the arms of researchers.
3. Agilent has launched a number of collaborative initiatives right here with companions like NUS, NTU, NCCS and NUH. Why are such partnerships so essential within the medical lab expertise house?
Partnerships carry complementary strengths collectively throughout educational rigour, medical perception and technological experience. That’s actually highly effective within the clinical-laboratory house, the place velocity and precision can straight impression affected person outcomes.
Take our collaboration with NUS Medication and NUH. We launched a S$38 million translational R&D hub in 2019 to spice up medical diagnostics and testing by means of biochemical innovation and methods. The alliance has since produced over 95 scientific publications and greater than 50 native and worldwide partnerships. Extra just lately, we partnered with NCCS to speed up genomic profiling of Asian-prevalent cancers utilizing our absolutely automated NGS library prep techniques.
We’re additionally working with NUS Medication to help cardiovascular and metabolic illness analysis by means of the brand new Centre of Excellence in Cell Metabolism. These are all structured, outcome-oriented collaborations that carry science from bench to bedside.
The best way I take a look at it’s: The world is our laboratory. Nice concepts don’t come from Agilent alone. By constructing the correct partnerships amongst authorities, business and academia in key areas of analysis, we will speed up science development and advance the standard of life.
4. How do these partnerships finally enhance Agilent’s choices for purchasers?
Our partnerships shut the hole between innovation and implementation. Working with main clinicians and researchers permits us to design applied sciences that match real-world lab workflows. That makes our options extra related and simpler to undertake.
It additionally hurries up the suggestions loop. We are able to check, validate and refine options in partnership with our collaborators, which shortens time-to-market and ensures that clients profit from scientific advances sooner.
One other essential side is native responsiveness. These partnerships deepen our understanding of market wants in Asia and assist us present extra tailor-made help in lots of aspects — from product design to service to training.
Going ahead, I feel what we’re going to see is even quicker reference to clients round a number of the most troublesome challenges we have now in our world.
5. Agilent can be pushing ahead with scalable AI and digital-lab options. What adjustments ought to clients anticipate?
By our World Resolution Growth Middle in Singapore and past, we’ve constructed a complete digital-lab ecosystem that transforms analysis labs’ potential into peak efficiency.
Our focus spans 4 key optimization areas: knowledge, devices, the lab setting and the broader enterprise. By integrating AI-driven insights with related applied sciences, we simplify complicated workflows, automate processes and improve knowledge accuracy throughout analysis and manufacturing.
Scientists can anticipate extra predictive analytics, seamless instrument connectivity and improved options that scale back labor-intensive workflows and variability. Harnessing Fourth Industrial Revolution (4IR) applied sciences, we drive effectivity and sustainability—whether or not it’s how our devices work or the best way we construct them. Our dedication is demonstrated by means of 4 sensible factories acknowledged by the World Financial Discussion board for his or her breakthroughs in scaling 4IR.
It’s very clear that in immediately’s aggressive panorama, digitalization is not a “nice-to-have.” Digitalization is foundational to how labs carry out and we’re proud to assist our clients lead that transition.
6. Wanting forward, what’s your imaginative and prescient for Agilent within the subsequent 5 years?
We try to be much more customer-centric. That’s the core of the whole lot we’re doing. We’re persevering with to spend money on innovation—each natural and thru M&A, and we’re increasing into high-growth adjacencies.
We’re additionally enabling better automation and enhancing our software program capabilities to help labs world wide. The purpose is to make it simpler for purchasers to resolve complicated challenges, whether or not that’s rushing up therapeutic improvement or detecting microplastics extra successfully.
Finally, we’re constructing a permanent firm that may assist speed up scientific progress whereas staying deeply related to the individuals who use our applied sciences on daily basis.
—
Supply: Agilent Applied sciences
Disclaimer: This text doesn’t essentially mirror the views of AsianScientist or its employees.
.jpg "Unlock Your Potential: How a Business Coach Can Transform Your Success")
